Global Diabetic Nephropathy Market to Expand at a Healthy CAGR of 5.6 % during the Forecast Period of 2014 – 2020

Growing prevalence of diabetes and obesity, increasing R&D investments in drug discovery and development, and rising awareness about diabetes and kidney-related disorders are some of the major drivers of the diabetic nephropathy market. A new research report with a title “Global Market Study on Diabetic Nephropathy: Asia to Witness Highest Growth by 2020” has been added to the vast online database of Market Research Reports Search Engine (MRRSE). The report analyzes the present market situation as well as the future potential of the global diabetic nephropathy market.

Request for sample report:

The global diabetic nephropathy market is projected to rise at a CAGR of 5.6% during the period of 2014 to 2020. At this rate, the market is expected to reach a valuation of USD 3,145.9 million in 2020 from USD 2,262.2 million in 2014.

Diabetes is an illness characterized by high blood sugar level in the blood which is caused by faulty functioning of the pancreas, the organ secretes insulin in the body which control the sugar level. Diabetic nephropathy is a disease of the kidney glomerulus and considered to be one of the most major complications based on mortality and morbidity for patients with diabetes. The disease is primarily characterized by macro-albuminuria, in which a single day presence of albumin in the urine can increase to over 300 milligrams. Besides this, diabetic nephropathy is also caused by imbalanced glomerular filtration rate, proteinuria and hypertension.

This report offers an in-depth analysis and projection of the diabetic nephropathy market for the years from 2014 to 2020, taking 2013 as the base year. Data regarding the current market dynamics, including market drivers, restraints, risks, trends, and recent developments is provided within the report. The diabetic nephropathy market is classified on the basis of mode of treatment and geography. Based on a mode of treatment for diabetic nephropathy, the market segments includes DMT. DMT is further categorized into diuretics, ACE inhibitors, ARBs, renin inhibitors, calcium channel blockers (CCBs), connective tissue growth factor (CTGF) inhibitors, antioxidant inflammation modulators (AIMs), endothelin-A receptor (ETAR) antagonist, monocyte chemoattractant protein (MCP) inhibitors, G protein-coupled receptors (GPCRs), and others. On the basis of geography, the report identifies and studies the market size and forecasts for Asia, North America, Europe, and Rest of the World (RoW).

North America has the biggest market for diabetic nephropathy, followed by Europe. Some of the fastest expanding markets for diabetic nephropathy include China and Japan. This is due to rise in the diabetic population and increase in incidence rates of several kidney diseases in different regions. Some of the major players in the diabetic nephropathy market include Novartis AG, Merck & Co., Inc., Reata Pharmaceuticals, Inc., Pfizer, Inc., Abbott Laboratories, Sanofi, Eli Lilly Company, Bayer AG, AbbVie, Inc., Mitsubishi Tanabe Pharma Corporation and Other. These key market players have been profiled on the basis of attributes such as company overview, financial overview, major recent developments, growth strategies, sustainability, and financial overview.

Browse Full Global Diabetic Nephropathy Market  Report with TOC :

About Us

Market Research Reports Search Engine (MRRSE) is an industry-leading database of market intelligence reports. MRRSE is driven by a stellar team of research experts and advisors trained to offer objective advice. Our sophisticated search algorithm returns results based on the report title, geographical region, publisher, or other keywords.

MRRSE partners exclusively with leading global publishers to provide clients single-point access to top-of-the-line market research. MRRSE’s repository is updated every day to keep its clients ahead of the next new trend in market research, be it competitive intelligence, product or service trends or strategic consulting.


State Tower
90, State Street
Suite 700
Albany, NY – 12207
United States

Telephone: +1-518-730-0559


Designed by
Powered by